These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16439944)

  • 1. [Modern views of diabetic angiopathy of the lower limbs (epidemiology, risk factor, etiopathogenesis, atherosclerosis of diabetes mellitus). Part I].
    Losev RZ; Kulikova AN
    Angiol Sosud Khir; 2005; 11(3):14-20. PubMed ID: 16439944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetic macroangiopathies of the lower extremities].
    Erdmanis DF
    Arkh Patol; 1986; 48(11):26-33. PubMed ID: 3827619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macroangiopathy in adults and children with diabetes: from molecular mechanisms to vascular damage (part 1).
    Di Marzio D; Mohn A; Mokini ZH; Giannini C; Chiarelli F
    Horm Metab Res; 2006 Nov; 38(11):691-705. PubMed ID: 17111296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetic peripheral arterial disease].
    Hofírek I; Vojtísek B
    Vnitr Lek; 2003 Dec; 49(12):911-5. PubMed ID: 15040154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which diabetics are at risk for lower-extremity problems and what preventive measures can be taken?
    Nair DG; Samson R
    Semin Vasc Surg; 2008 Sep; 21(3):154-9. PubMed ID: 18774451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
    Romero P; Baget M; Mendez I; Fernández J; Salvat M; Martinez I
    J Diabetes Complications; 2007; 21(3):172-80. PubMed ID: 17493551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of diabetic macroangiopathy of the lower extremities].
    Tkác I; Takác M
    Vnitr Lek; 1992 Feb; 38(2):184-90. PubMed ID: 1595208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular risks and complications in diabetes mellitus: the role of helicobacter pylori infection.
    Hamed SA; Amine NF; Galal GM; Helal SR; Tag El-Din LM; Shawky OA; Ahmed EA; Abdel Rahman MS
    J Stroke Cerebrovasc Dis; 2008; 17(2):86-94. PubMed ID: 18346651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic microvascular complications--can the presence of one predict the development of another?
    Girach A; Vignati L
    J Diabetes Complications; 2006; 20(4):228-37. PubMed ID: 16798474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebral vascular pathology in diabetes].
    Arquizan C
    Arch Mal Coeur Vaiss; 2004 Dec; 97 Spec No 3():29-32. PubMed ID: 15666479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced aortic wall stress in diabetes mellitus.
    Astrand H; Rydén-Ahlgren A; Sundkvist G; Sandgren T; Länne T
    Eur J Vasc Endovasc Surg; 2007 May; 33(5):592-8. PubMed ID: 17164093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study.
    Gorter PM; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2007 Dec; 24(12):1352-60. PubMed ID: 18042079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The altered homeostatic theory: A hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes--including reducing the risk of age and atherosclerosis.
    Hellstrom HR
    Med Hypotheses; 2007; 68(2):415-33. PubMed ID: 16828234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Where and in which blood vessels does atherosclerosis manifest itself?].
    Skowasch D; Bauriedel G
    Dtsch Med Wochenschr; 2005 Dec; 130(48):2789. PubMed ID: 16307410
    [No Abstract]   [Full Text] [Related]  

  • 15. [Special features of strokes in diabetics].
    Baros V; Rybka J
    Vnitr Lek; 1997 Jan; 43(1):34-6. PubMed ID: 9221564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice.
    Nilsson-Ohman J; Fredrikson GN; Nilsson-Berglund LM; Gustavsson C; Bengtsson E; Smith ML; Agardh CD; Agardh E; Jovinge S; Gomez MF; Nilsson J
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1465-70. PubMed ID: 19755528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke prevention in diabetes and obesity.
    Kurukulasuriya LR; Govindarajan G; Sowers J
    Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):487-502. PubMed ID: 16918267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
    Milicevic Z; Raz I; Beattie SD; Campaigne BN; Sarwat S; Gromniak E; Kowalska I; Galic E; Tan M; Hanefeld M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S155-60. PubMed ID: 18227478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and cerebrovascular disease: which are the actual data?
    Hatzitolios AI; Didangelos TP; Zantidis AT; Tziomalos K; Giannakoulas GA; Karamitsos DT
    J Diabetes Complications; 2009; 23(4):283-96. PubMed ID: 18358748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral arterial disease in patients with diabetes.
    Marso SP; Hiatt WR
    J Am Coll Cardiol; 2006 Mar; 47(5):921-9. PubMed ID: 16516072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.